BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maagdenberg H, Oosterom N, Zanen J, Gemmati D, Windsor RE, Heil SG, Esperón P, Jabeen S, Ruiz-Argüelles GJ, Zolk O, Hoerning S, Sleurs C, Lopéz-Lopéz E, Moreno-Galván M, van den Heuvel-Eibrink MM, Maitland-van der Zee AH, Carleton BC. Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis. Crit Rev Oncol Hematol 2021;161:103312. [PMID: 33794308 DOI: 10.1016/j.critrevonc.2021.103312] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Song Z, Hu Y, Liu S, Jiang D, Yi Z, Benjamin MM, Zhao R. The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis. Front Pharmacol 2021;12:757464. [PMID: 34744734 DOI: 10.3389/fphar.2021.757464] [Reference Citation Analysis]
2 Han J, Liu L, Meng L, Guo H, Zhang J, Han ZQ, Hong ZY. Effect of Polymorphisms of ABCB1 and MTHFR on Methotrexate-Related Toxicities in Adults With Hematological Malignancies. Front Oncol 2021;11:759805. [PMID: 35004279 DOI: 10.3389/fonc.2021.759805] [Reference Citation Analysis]